Nautilus Biotechnology, Inc.

NAUT Nasdaq CIK: 0001808805

Company Information

Industry Laboratory Analytical Instruments
SIC Code 3826
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
Business Address 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
Mailing Address 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
Phone 206-333-2001
Fiscal Year End 1231
EIN 981541723

Financial Overview

FY2025

$34.14M
Total Liabilities

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC

Annual Reports

10-K February 26, 2026
  • Developing Nautilus Voyager™ platform for ultra-sensitive, high-throughput protein analysis.
  • Estimated total addressable market could reach tens of billions of dollars annually.
View Analysis

Insider Trading

BUY 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3826)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.